CMP Stock Analysis: Compass Minerals | NYSE
Other Industrial Metals & Mining | NYSE, USA | Market Cap: 1.257m USD | 12M Return: 33% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 14.2M
Qual. Beats: 0
Rev. Trend: 48.8%
Qual. Beats: 2
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Compass Minerals International (NYSE: CMP) is a U.S.-based producer of essential minerals operating through two segments: Salt and Plant Nutrition. The Salt segment manufactures and distributes sodium chloride and magnesium chloride products used for roadway deicing, water treatment, chemical production, and consumer/industrial applications, while also offering records management services. The Plant Nutrition segment produces sulfate of potash (SOP) specialty fertilizers under the Protakuan+ brand, along with turf and organic products for agricultural and ornamental markets.
As a Materials sector company classified under Diversified Metals & Mining, Compass Minerals benefits from recurring, infrastructure-linked demand for deicing salt in colder regions, though this exposes results to winter weather variability. Its SOP fertilizer business targets higher-margin specialty crop and turf applications rather than the broader commodity fertilizer market.
Founded in 1844 and formerly known as Salt Holdings Corporation before adopting its current name in December 2003, the company is headquartered in Overland Park, Kansas, and serves customers across the United States, Canada, the United Kingdom, and select international markets.
- Mild winter weather pressures North American deicing salt volumes
- Protassium+ SOP fertilizer pricing tracks global potash markets
- Elevated debt levels constrain capital allocation flexibility
| Net Income: 7.10m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 1.35 > 1.0 |
| NWC/Revenue: 20.25% < 20% (prev 21.24%; Δ -0.99% < -1%) |
| CFO/TA 0.13 > 3% & CFO 175.3m > Net Income 7.10m |
| Net Debt (657.6m) to EBITDA (201.6m): 3.26 < 3 |
| Current Ratio: 2.06 > 1.5 & < 3 |
| Outstanding Shares: last quarter (42.3m) vs 12m ago 1.87% < -2% |
| Gross Margin: 17.48% > 18% (prev 13.45%; Δ 4.04% > 0.5%) |
| Asset Turnover: 89.15% > 50% (prev 79.22%; Δ 9.93% > 0%) |
| Interest Coverage Ratio: 1.40 > 6 (EBIT TTM 97.1m / Interest Expense TTM 69.6m) |
| A: 0.19 (Total Current Assets 508.1m - Total Current Liabilities 246.6m) / Total Assets 1.37b |
| B: -0.03 (Retained Earnings -46.3m / Total Assets 1.37b) |
| C: 0.07 (EBIT TTM 97.1m / Avg Total Assets 1.45b) |
| D: 0.25 (Book Value of Equity 274.2m / Total Liabilities 1.09b) |
| Altman-Z'' = 1.86 = BBB |
| DSRI: 0.76 (Receivables 223.3m/274.6m, Revenue 1.29b/1.21b) |
| GMI: 0.77 (GM 13.45% / 17.48%) |
| AQI: 0.64 (AQ_t 0.08 / AQ_t-1 0.13) |
| SGI: 1.06 (Revenue 1.29b / 1.21b) |
| TATA: -0.12 (NI 7.10m - CFO 175.3m) / TA 1.37b) |
| Beneish M = -3.61 (Cap -4..+1) = AAA |
As of July 11, 2026, the stock is trading at USD 29.84 with a total of 246,439 shares traded. Over the past week, the price has changed by -0.37%, over one month by +3.07%, over three months by +20.32% and over the past year by +32.98%.
Current recommended Stop Loss: 28.10 (which is 5.8% or 1.3 ATR below the current price).
Compass Minerals has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy CMP.
- StrongBuy: 1
- Buy: 3
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 32.3 | 8.1% |
P/E Trailing = 187.1875
P/E Forward = 14.771
P/S = 0.9731
P/B = 4.583
P/EG = 0.1192
Revenue TTM = 1.29b USD
EBIT TTM = 97.1m USD
EBITDA TTM = 201.6m USD
Long Term Debt = 713.0m USD (from longTermDebt, last quarter)
Short Term Debt = 6.40m USD (from shortTermDebt, last quarter)
Debt = 731.7m USD (corrected: LT Debt 713.0m + ST Debt 6.40m) + Leases 12.3m
Net Debt = 657.6m USD (calculated: Debt 731.7m - CCE 74.1m)
Enterprise Value = 1.91b USD (1.26b + Debt 731.7m - CCE 74.1m)
Interest Coverage Ratio = 1.40 (Ebit TTM 97.1m / Interest Expense TTM 69.6m)
EV/FCF = 19.07x (Enterprise Value 1.91b / FCF TTM 100.4m)
FCF Yield = 5.24% (FCF TTM 100.4m / Enterprise Value 1.91b)
FCF Margin = 7.77% (FCF TTM 100.4m / Revenue TTM 1.29b)
Net Margin = 0.55% (Net Income TTM 7.10m / Revenue TTM 1.29b)
Gross Margin = 17.48% ((Revenue TTM 1.29b - Cost of Revenue TTM 1.07b) / Revenue TTM)
Gross Margin QoQ = 18.31% (prev 15.96%)
Tobins Q-Ratio = 1.40 (Enterprise Value 1.91b / Total Assets 1.37b)
Interest Expense / Debt = 9.51% (Interest Expense 69.6m / Debt 731.7m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = 76.7m (EBIT 97.1m * (1 - 21.00%))
Current Ratio = 2.06 (Total Current Assets 508.1m / Total Current Liabilities 246.6m)
Debt / Equity = 2.67 (Debt 731.7m / totalStockholderEquity, last quarter 274.2m)
Debt / EBITDA = 3.26 (Net Debt 657.6m / EBITDA 201.6m)
Debt / FCF = 6.55 (Net Debt 657.6m / FCF TTM 100.4m)
Total Stockholder Equity = 254.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.49% (Net Income 7.10m / Total Assets 1.37b)
RoE = 2.79% (Net Income TTM 7.10m / Total Stockholder Equity 254.7m)
RoCE = 10.03% (EBIT 97.1m / Capital Employed (Equity 254.7m + L.T.Debt 713.0m))
RoIC = 7.23% (NOPAT 76.7m / Invested Capital 1.06b)
WACC = 9.89% (E(1.26b)/V(1.99b) * Re(11.28%) + D(731.7m)/V(1.99b) * Rd(9.51%) * (1-Tc(0.21)))
Discount Rate = 11.28% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 100.00 | Cagr: 1.17%
[DCF] Terminal Value 71.53% ; FCFF base≈97.0m ; Y1≈104.9m ; Y5≈128.7m
[DCF] Fair Price = 21.42 (EV 1.56b - Net Debt 657.6m = Equity 898.8m / Shares 42.0m; r=9.89% [WACC]; 5y FCF grow 9.25% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.07 | # QB: 0
Revenue Correlation: 48.84 | Revenue CAGR: 3.27% | SUE: 0.93 | # QB: 2
EPS current Quarter (2026-06-30): EPS=-0.06 | Chg30d=+0.00% | Revisions=+0% | Analysts=4
EPS current Year (2026-09-30): EPS=0.82 | Chg30d=-5.57% | Revisions=+0% | GrowthEPS=+270.6% | GrowthRev=+2.9%
EPS next Year (2027-09-30): EPS=1.18 | Chg30d=+4.66% | Revisions=+57% | GrowthEPS=+44.4% | GrowthRev=+3.3%
[Analyst] Revisions Ratio: +27% (up=8, down=4)